These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16981244)

  • 21. Haemangioblastoma of the central nervous system in von Hippel-Lindau disease. French VHL Study Group.
    Richard S; Campello C; Taillandier L; Parker F; Resche F
    J Intern Med; 1998 Jun; 243(6):547-53. PubMed ID: 9681857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metastasis of renal cell carcinoma to haemangioblastoma of the spinal cord in von Hippel-Lindau disease: case report and review of the literature.
    Abou-Hamden A; Koszyca B; Carney PG; Sandhu N; Blumbergs PC
    Pathology; 2003 Jun; 35(3):224-7. PubMed ID: 14506966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway.
    Blancher C; Moore JW; Robertson N; Harris AL
    Cancer Res; 2001 Oct; 61(19):7349-55. PubMed ID: 11585776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.
    Maxwell PH; Wiesener MS; Chang GW; Clifford SC; Vaux EC; Cockman ME; Wykoff CC; Pugh CW; Maher ER; Ratcliffe PJ
    Nature; 1999 May; 399(6733):271-5. PubMed ID: 10353251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of growth factors and growth factor receptors in capillary hemangioblastoma.
    Böhling T; Hatva E; Kujala M; Claesson-Welsh L; Alitalo K; Haltia M
    J Neuropathol Exp Neurol; 1996 May; 55(5):522-7. PubMed ID: 8627342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease.
    Zatyka M; da Silva NF; Clifford SC; Morris MR; Wiesener MS; Eckardt KU; Houlston RS; Richards FM; Latif F; Maher ER
    Cancer Res; 2002 Jul; 62(13):3803-11. PubMed ID: 12097293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Up-regulation of vascular endothelial growth factor in stromal cells of hemangioblastomas is correlated with up-regulation of the transcription factor HRF/HIF-2alpha.
    Flamme I; Krieg M; Plate KH
    Am J Pathol; 1998 Jul; 153(1):25-9. PubMed ID: 9665461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Developmentally arrested structures preceding cerebellar tumors in von Hippel-Lindau disease.
    Shively SB; Falke EA; Li J; Tran MG; Thompson ER; Maxwell PH; Roessler E; Oldfield EH; Lonser RR; Vortmeyer AO
    Mod Pathol; 2011 Aug; 24(8):1023-30. PubMed ID: 21499240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fibrosis and hypoxia-inducible factor-1α-dependent tumors of the soft tissue on loss of von Hippel-Lindau in mesenchymal progenitors.
    Mangiavini L; Merceron C; Araldi E; Khatri R; Gerard-O'Riley R; Wilson TL; Sandusky G; Abadie J; Lyons KM; Giaccia AJ; Schipani E
    Am J Pathol; 2015 Nov; 185(11):3090-101. PubMed ID: 26348575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. VHL-deficient vasculogenesis in hemangioblastoma.
    Gläsker S; Smith J; Raffeld M; Li J; Oldfield EH; Vortmeyer AO
    Exp Mol Pathol; 2014 Apr; 96(2):162-7. PubMed ID: 24394472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The expression of hypoxia inducible factor-1,2 alpha in sporadic clear cell renal cell carcinoma and their relationships to the mutations of von Hippel-Lindau gene].
    Gong K; Zhang N; Na X; Wu G; Yang XY; Xin DQ; Na YQ
    Zhonghua Wai Ke Za Zhi; 2005 Mar; 43(6):390-3. PubMed ID: 15854350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro and in vivo models analyzing von Hippel-Lindau disease-specific mutations.
    Rathmell WK; Hickey MM; Bezman NA; Chmielecki CA; Carraway NC; Simon MC
    Cancer Res; 2004 Dec; 64(23):8595-603. PubMed ID: 15574766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of radiation and ibuprofen on normoxic renal carcinoma cells overexpressing hypoxia-inducible factors by loss of von Hippel-Lindau tumor suppressor gene function.
    Palayoor ST; Burgos MA; Shoaibi A; Tofilon PJ; Coleman CN
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4158-64. PubMed ID: 15217953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Essentials and pitfalls in the treatment of CNS hemangioblastomas and von Hippel-Lindau disease.
    Gläsker S; Klingler JH; Müller K; Würtenberger C; Hader C; Zentner J; Neumann HP; Velthoven VV
    Cent Eur Neurosurg; 2010 May; 71(2):80-7. PubMed ID: 20229452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. VHL mutation analysis in patients with isolated central nervous system haemangioblastoma.
    Woodward ER; Wall K; Forsyth J; Macdonald F; Maher ER
    Brain; 2007 Mar; 130(Pt 3):836-42. PubMed ID: 17264095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progression of epididymal maldevelopment into hamartoma-like neoplasia in VHL disease.
    Mehta GU; Shively SB; Duong H; Tran MG; Moncrief TJ; Smith JH; Li J; Edwards NA; Lonser RR; Zhuang Z; Merrill MJ; Raffeld M; Maxwell PH; Oldfield EH; Vortmeyer AO
    Neoplasia; 2008 Oct; 10(10):1146-53. PubMed ID: 18813354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Von Hippel-Lindau disease.
    Sano T; Horiguchi H
    Microsc Res Tech; 2003 Feb; 60(2):159-64. PubMed ID: 12539169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metastases to hemangioblastomas in von Hippel-Lindau disease.
    Jarrell ST; Vortmeyer AO; Linehan WM; Oldfield EH; Lonser RR
    J Neurosurg; 2006 Aug; 105(2):256-63. PubMed ID: 17219831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The natural history of hemangioblastomas of the central nervous system in patients with von Hippel-Lindau disease.
    Wanebo JE; Lonser RR; Glenn GM; Oldfield EH
    J Neurosurg; 2003 Jan; 98(1):82-94. PubMed ID: 12546356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Notch receptor and effector expression in von Hippel-Lindau disease-associated central nervous system hemangioblastomas.
    Merrill MJ; Edwards NA; Lonser RR
    J Neurosurg; 2011 Sep; 115(3):512-7. PubMed ID: 21663414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.